NHS Framework Agreement, Branded Medicines for London and South of England
Details
- Buyer
- NHS England
- Value
- GBP 1,110,294,056
- Topic
- Pharmaceutical products
- Published
- 30 April 2021
- Submission
- 4 June 2021
- Source
- uk:find_a_tender
Tender description
NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab. Lot 1: CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B. CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months Lot 4: CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B. CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 2: CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche. CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 3: CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A. CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 6: CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab Lot 5: CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche. CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 1: CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B. CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months Lot 4: CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B. CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 2: CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche. CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 3: CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A. CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 6: CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab Lot 5: CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche. CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Timeline
- Completed: Tender published30 April 2021Current notice
- Completed: Submission date4 June 2021
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework Agreement, Branded Medicines for London and South of England.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 353£15.0bn
- 293£2.8bn
- 261£19.7bn
- 252£892.4m
- 243£509.0m
- 203£1.0bn
- 140£895.5m
- 114£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
